Utilizing advanced technology to tackle efficient biopharmaceutical design.
Digital design of biopharmaceuticals with workflows tailored to project needs.
By using cutting-edge computer modeling technology from Schrödinger and an enterprise informatics platform, it becomes possible to rationally design high-quality biopharmaceuticals such as monoclonal antibodies, vaccines, enzymes, and peptides. - Prediction of protein structures, their refinement, and dynamics - Detection and mitigation of physicochemical issues - Prediction and analysis of protein interactions - Protein design through In Silico Mutagenesis - Visualization and analysis of sequences - Analysis of molecular and thermodynamic properties - Design of fusion proteins and linkers *For more details, please feel free to contact us.*
- Company：シュレーディンガー
- Price：Other
